These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 35422206)

  • 21. Nano-based drug delivery system: a smart alternative towards eradication of viral sanctuaries in management of NeuroAIDS.
    Aggarwal N; Sachin ; Nabi B; Aggarwal S; Baboota S; Ali J
    Drug Deliv Transl Res; 2022 Jan; 12(1):27-48. PubMed ID: 33486689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategic targeting of non-small-cell lung cancer utilizing genetic material-based delivery platforms of nanotechnology.
    Chaudhary S; Singh A; Kumar P; Kaushik M
    J Biochem Mol Toxicol; 2021 Jul; 35(7):e22784. PubMed ID: 33826765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanomedicine for the management of lung and blood diseases.
    Buxton DB
    Nanomedicine (Lond); 2009 Apr; 4(3):331-9. PubMed ID: 19331540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanotherapeutics: An insight into healthcare and multi-dimensional applications in medical sector of the modern world.
    Prasad M; Lambe UP; Brar B; Shah I; J M; Ranjan K; Rao R; Kumar S; Mahant S; Khurana SK; Iqbal HMN; Dhama K; Misri J; Prasad G
    Biomed Pharmacother; 2018 Jan; 97():1521-1537. PubMed ID: 29793315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone targeted nano-drug and nano-delivery.
    Wu Y; Sun B; Tang Y; Shen A; Lin Y; Zhao X; Li J; Monteiro MJ; Gu W
    Bone Res; 2024 Sep; 12(1):51. PubMed ID: 39231955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combinatorial Nanoparticle Delivery of siRNA and Antineoplastics for Lung Cancer Treatment.
    Ahmed R; Amreddy N; Babu A; Munshi A; Ramesh R
    Methods Mol Biol; 2019; 1974():265-290. PubMed ID: 31099010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanotechnology in medicine revolutionizing drug delivery for cancer and viral infection treatments.
    Karahmet Sher E; Alebić M; Marković Boras M; Boškailo E; Karahmet Farhat E; Karahmet A; Pavlović B; Sher F; Lekić L
    Int J Pharm; 2024 Jul; 660():124345. PubMed ID: 38885775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ten Years of Knowledge of Nano-Carrier Based Drug Delivery Systems in Ophthalmology: Current Evidence, Challenges, and Future Prospective.
    Zhang J; Jiao J; Niu M; Gao X; Zhang G; Yu H; Yang X; Liu L
    Int J Nanomedicine; 2021; 16():6497-6530. PubMed ID: 34588777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances on nanoparticle-based therapies for cardiovascular diseases.
    Soumya RS; Raghu KG
    J Cardiol; 2023 Jan; 81(1):10-18. PubMed ID: 35210166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Comprehensive Review on Nanoparticles as a Targeted Delivery System for the Treatment of Lung Cancer.
    Gupta T; Varanwal A; Nema P; Soni S; Iyer AK; Das R; Soni V; Kashaw SK
    Anticancer Agents Med Chem; 2024; 24(3):157-168. PubMed ID: 38013441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nano delivery system for paclitaxel: Recent advances in cancer theranostics.
    Ying N; Liu S; Zhang M; Cheng J; Luo L; Jiang J; Shi G; Wu S; Ji J; Su H; Pan H; Zeng D
    Colloids Surf B Biointerfaces; 2023 Aug; 228():113419. PubMed ID: 37393700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination therapy based on targeted nano drug co-delivery systems for liver fibrosis treatment: a review.
    Zhou L; Li Y; Liang Q; Liu J; Liu Y
    J Drug Target; 2022 Jul; 30(6):577-588. PubMed ID: 35179094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancing therapy with nano-based delivery systems: exploring the bioactive properties and effects of apigenin.
    Kumar G; Jain P; Virmani T; Sharma A; Akhtar MS; Aldosari SA; Khan MF; Duarte SOD; Fonte P
    Ther Deliv; 2024; 15(9):717-735. PubMed ID: 39259258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advancements in nanotherapeutics for Alzheimer's disease: current perspectives.
    Harilal S; Jose J; Parambi DGT; Kumar R; Mathew GE; Uddin MS; Kim H; Mathew B
    J Pharm Pharmacol; 2019 Sep; 71(9):1370-1383. PubMed ID: 31304982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanoparticles Mediated Target-specific Drug Delivery in Prostate Cancer: An In-depth Review.
    Upadhyay TK; Ali MI; Khan F; Goel H; Mathur M; Goyal K; Moin S; Pandey P; Tanwar P; Sharangi AB; Gautam SDC; Kapdi JK; Patel KI; Patel MV; Parmar AM; Kamal MA
    Curr Med Chem; 2022; 29(24):4170-4184. PubMed ID: 34939536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances of smart nano-drug delivery systems in osteosarcoma treatment.
    Liu Y; Li Q; Bai Q; Jiang W
    J Mater Chem B; 2021 Jul; 9(27):5439-5450. PubMed ID: 34155495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy - an illustration with firsthand examples.
    Zhang RX; Li J; Zhang T; Amini MA; He C; Lu B; Ahmed T; Lip H; Rauth AM; Wu XY
    Acta Pharmacol Sin; 2018 May; 39(5):825-844. PubMed ID: 29698389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein-Based Nanocarriers and Nanotherapeutics for Infection and Inflammation.
    Nagar N; Naidu G; Mishra A; Poluri KM
    J Pharmacol Exp Ther; 2024 Jan; 388(1):91-109. PubMed ID: 37699711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nano cancer therapy strategies.
    Tiwari M
    J Cancer Res Ther; 2012; 8(1):19-22. PubMed ID: 22531508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.
    Milane L; Ganesh S; Shah S; Duan ZF; Amiji M
    J Control Release; 2011 Oct; 155(2):237-47. PubMed ID: 21497176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.